Inventurus Knowledge Solutions Limited has informed the Exchange about Investor Presentation
IKS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
IKS Health reported strong Q4 FY26 results with revenue of Rs 8,577 million (18% YoY growth) and EBITDA of Rs 3,002 million (32.7% YoY growth), with margins expanding significantly. For full FY26, revenue grew 20% YoY to Rs 31,938 million while EBITDA margin improved from 29.7% to 34.2% and PAT margin from 18.2% to 22.6%. The company announced two strategic acquisitions: TruBridge (EHR for rural/community hospitals) and ARAI (AI company with knowledge graph IP). Key wins include a multi-year platform partnership with Holyoke Medical Center and expansion with a Top 5 Health System. The company also disclosed FY2030 targets of Rs 3,000 crore EBITDA with ~Rs 300 crore net debt through its AI-first strategy.
The consistent margin expansion and disclosed FY2030 targets signal strong execution capability and future growth visibility. The proposed acquisitions of TruBridge and ARAI could significantly enhance IKS Health's platform moat by integrating EHR (System of Record) with their AI-powered care enablement platform.